Cefazolin and Ertapenem Salvage Therapy Rapidly Clears Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia

被引：29
|
作者：
Ulloa, Erlinda R. [1 ,2 ]
Singh, Kavindra, V [3 ,4 ]
Geriak, Matthew [5 ]
Haddad, Fadi [6 ]
Murray, Barbara E. [3 ,4 ]
Nizet, Victor [1 ,7 ]
Sakoulas, George [1 ,5 ]
机构：
[1] Univ Calif San Diego, Sch Med, Dept Pediat, Collaborat Halt Antibiot Resistant Microbes, La Jolla, CA 92093 USA
[2] Childrens Hosp Philadelphia, Dept Pediat, Div Infect Dis, Philadelphia, PA 19104 USA
[3] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Internal Med, Div Infect Dis, Houston, TX 77030 USA
[4] Univ Texas Hlth Sci Ctr Houston, Ctr Antimicrobial Resistance & Microbial Genom, McGovern Med Sch, Houston, TX 77030 USA
[5] Sharp Mem Hosp & Rehabil Ctr, San Diego, CA USA
[6] Sharp Grossmont Hosp, La Mesa, CA USA
[7] Univ Calif San Diego, Skaggs Sch Pharm, La Jolla, CA 92093 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2020年 / 71卷 / 06期
基金：
美国国家卫生研究院;
关键词：
Staphylococcus aureus; bacteremia; endocarditis; cefazolin; ertapenem; PENICILLIN-BINDING PROTEINS; ENDOCARDITIS; MANAGEMENT; OXACILLIN; SYNERGY;
D O I：
10.1093/cid/ciz995
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Cefazolin and ertapenem combination therapy was used successfully to salvage 11 cases (6 endocarditis) of persistent methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia, including immediate clearance (<= 24 hours) in 8 cases. While in vitro synergy was modest, cefazolin plus ertapenem exhibited synergistic action in a rat model of MSSA endocarditis. The combination of cefazolin and ertapenem provides potent in vivo activity against MSSA beyond what is predicted in vitro and warrants further clinical study in the treatment of refractory MSSA bacteremia and endocarditis. Cefazolin and ertapenem combination therapy yielded profound clinical success in 11 severe methicillin-susceptible Staphylococcus aureus infections with high bacterial densities (6 endocarditis), as demonstrated by rapid bacteremia clearance. Enhanced efficacy was also observed in a rat endocarditis model.
引用
收藏
页码：1413 / 1418
页数：6
相关论文
共 50 条
  • [21] Comparison of Cefazolin versus Oxacillin for Treatment of Complicated Bacteremia Caused by Methicillin-Susceptible Staphylococcus aureus
    Li, Julius
    Echevarria, Kelly L.
    Hughes, Darrel W.
    Cadena, Jose A.
    Bowling, Jason E.
    Lewis, James S., II
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (09) : 5117 - 5124
  • [22] Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus
    Gern, Benjamin H.
    Greninger, Alexander L.
    Weissman, Scott J.
    Stapp, Jennifer R.
    Tao, Yue
    Qin, Xuan
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2018, 17
  • [23] Clinical Implications of Cefazolin Inoculum Effect and β-Lactamase Type on Methicillin-Susceptible Staphylococcus aureus Bacteremia
    Lee, Shinwon
    Kwon, Ki Tae
    Kim, Hye-In
    Chang, Hyun Ha
    Lee, Jong-Myung
    Choe, Pyoeng Gyun
    Park, Wan Beom
    Kim, Nam Joong
    Oh, Myoung-Don
    Song, Do Young
    Kim, Shin-Woo
    MICROBIAL DRUG RESISTANCE, 2014, 20 (06) : 568 - 574
  • [24] CEFTAROLINE AS SALVAGE THERAPY FOR METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS COMPLICATED BACTEREMIA
    Obed, Mora N.
    Toresani, Ines
    Mykietuk, Analia
    Nannini, Esteban C.
    MEDICINA-BUENOS AIRES, 2022, 82 (05) : 794 - 797
  • [25] Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus
    Benjamin H. Gern
    Alexander L. Greninger
    Scott J. Weissman
    Jennifer R. Stapp
    Yue Tao
    Xuan Qin
    Annals of Clinical Microbiology and Antimicrobials, 17
  • [26] DEVASTATING METHICILLIN-SUSCEPTIBLE STAPHYLOCOCCUS AUREUS BACTEREMIA WITH AN UNKNOWN SOURCE
    Kagita, Navyamani V.
    Thota, Vihitha
    Jain, Akhil
    Ikoro, Udunma N.
    Sheu, Wei-Chun
    Russell, Steven
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S324 - S324
  • [27] Cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus clinical isolates
    Tsuji, Shuma
    Gotoh, Kazuyoshi
    Manabe, Tadahiro
    Iio, Koji
    Fukushima, Shinnosuke
    Matsushita, Osamu
    Hagiya, Hideharu
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2024, 110 (01)
  • [28] Ceftriaxone versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteraemia
    Mohamed, Adham
    Bennett, Nicholas
    Ploetz, Jeannette
    Aragon, Laura
    Kennedy, Kevin
    Boyd, Sarah
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 60 (03)
  • [29] Post-treatment outcomes of ceftriaxone versus antistaphylococcal penicillins or cefazolin for definitive therapy of methicillin-susceptible Staphylococcus aureus bacteremia
    Yetmar, Zachary A.
    Khodadadi, Ryan B.
    Go, John Raymond
    Chesdachai, Supavit
    Abu Saleh, Omar M.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2023, 42 (04) : 423 - 430
  • [30] Therapeutic Options for Adult Patients With Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Narrative Review
    Chastain, Daniel B.
    Covert, Kelly L.
    Tu, Patrick J.
    McDougal, Steven
    White, Bryan P.
    Cluck, David
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (11) : 1312 - 1327
12345